D2V-32939-49987
4 vaccinations
3 coded responses
17 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Registered in v-safe
- 2021-03-21
- 2021-03-22
- 2021-03-29
-
2021-03-30
Dose 2 — Pfizer-BioNTech
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-13
Pregnancy registry surveyPregnant at time of vaccination · Yes, I would like someone to contact me
- 2021-04-22
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-06-29
- 2021-09-28
-
2021-11-16
Dose 3 — Pfizer-BioNTech
-
2022-03-30
Survey response — 12 month, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-09-12
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-05
Survey response — 21 day, dose 4MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-10-05
Report sent to call center — 21 day, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-06
- 2022-10-17
- 2022-12-12
-
2023-03-13
Survey response — 6 month, dose 4MedDRA: Deafness, Ear infection, Eustachian tube dysfunction, Nasopharyngitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2023-03-13
Report sent to call center — 6 month, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-14
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Pfizer-BioNTech | No |
| 4 | 2022-09-12 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-05 | Unsuccessful | |
| 2023-03-13 | Unsuccessful |
Free text
Release 11
Symptoms: Congestion, general cold symptoms
Release 12
Symptoms: Cough, congestion
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Deafness | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Eustachian tube dysfunction | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release